Advances in Colorectal Cancer Organoids for Precision Medicine
Author Information
Author(s): Zhang Yanan, Meng Ruoyu, Sha Dan, Gao Huiquan, Wang Shengxi, Zhou Jun, Wang Xiaoshan, Li Fuxia, Li Xinyu, Song Wei
Primary Institution: The First Clinical Medical College of Shandong University of Traditional Chinese Medicine
Hypothesis
Colorectal cancer organoids can enhance precision medicine by accurately modeling tumor characteristics and responses to treatment.
Conclusion
Colorectal cancer organoids are effective models for studying tumor biology and developing personalized treatment strategies.
Supporting Evidence
- Colorectal cancer organoids closely mimic the original tumor tissue and maintain stable phenotypic structures.
- Organoid technology has advanced individualized tumor therapies and drug development.
- Integration of single-cell technology enhances insights into tumor heterogeneity and treatment responses.
- Patient-derived organoids can predict responses to chemotherapy and targeted therapies.
Takeaway
Scientists are using tiny models of tumors called organoids to better understand and treat colorectal cancer, making treatments more personalized for each patient.
Methodology
The review discusses the evolution of colorectal cancer organoid technology, its applications in precision medicine, and the integration of single-cell technology.
Limitations
Organoids cannot fully replicate the complex in vivo tumor microenvironment and may lack dynamic physiological changes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website